1672-4992
2014 Issue 7
NDRG2 regulates HGF/c-MET signaling pathway to inhibit the proliferation of colon cancer cells
Ma Yongzheng;,Wei Yifang;,Yao Libo;,Zhang Jian;
Ma Yongzheng;,Wei Yifang;,Yao Libo;,Zhang Jian;
..............page:1479-1482
Screen of micro-scaled stainless steel agent for cancer magnetic mediated hyperthermia
Cui Ruirui;,Tang Jintian;,Wang Xiaowen;,Wei Lanbin;
Cui Ruirui;,Tang Jintian;,Wang Xiaowen;,Wei Lanbin;
..............page:1483-1488
Methylation of promoter in EEN-B1 gene and its impact on expression in vulvar squamous cell carcinomas
He Yinghui;,Ouyang Ling;
He Yinghui;,Ouyang Ling;
..............page:1488-1491
Screen and identification of monoclonal antibody against pancreatic cancer stem cells
jie yi bin ;, liu hui zuo ;, mo wen xiu ;, ran yu zuo ;, sun li chao ;, sun li xin ;, yang zhi hua ;, yu zuo ;
jie yi bin ;, liu hui zuo ;, mo wen xiu ;, ran yu zuo ;, sun li chao ;, sun li xin ;, yang zhi hua ;, yu zuo ;
..............page:1492-1496
Application of Ca2+ indicators of the fluorescent protein Cameleon and the fluorescent dye fluo-3 in H2O2 stimulated A549 cells
Cui Zeshi;,Gao Jian;,Qiu Xueshan;,Yu Miao;,Zhang Siyang;,Zhou Mo;
Cui Zeshi;,Gao Jian;,Qiu Xueshan;,Yu Miao;,Zhang Siyang;,Zhou Mo;
..............page:1497-1501
TNF-α/IFN-γ induced FAT10 expression and abnormal chromosome karyotype in TPC-1 cells
Gao Yun;,Shang Xueying;
Gao Yun;,Shang Xueying;
..............page:1501-1503
The inhbifting effect of different ultrasound parameters on tumor cell growth
kang xiao ning ;, li hong li ;, liao zuo ran ;, qi chao ;, ren shu zuo ;, sun peng fei ;, wang bing ;, zhang hui ;, zhao xing hua ;
kang xiao ning ;, li hong li ;, liao zuo ran ;, qi chao ;, ren shu zuo ;, sun peng fei ;, wang bing ;, zhang hui ;, zhao xing hua ;
..............page:1504-1507
The effect of over-expression of Axin on the biological behavior of glioma U87 cells and its mechanism
Ding Caixia;,Li Qing;,Lu Jianrong;,Zhang Juan;
Ding Caixia;,Li Qing;,Lu Jianrong;,Zhang Juan;
..............page:1507-1510
..............page:1510,1553,1666
Effect of endostar on the growth and apoptosis of lung cancer A549 cells
Chen Fuhui;,Xia Rongyao;,Zhang Ranran;
Chen Fuhui;,Xia Rongyao;,Zhang Ranran;
..............page:1511-1514
Preventive effects of fisetin on bladder cancer in rats and its mechanisms
cheng yong yi ;, jiang ya zhuo ;, li jing ;, qu wei xing ;, wu min ;, yu yi ;, zhao hua cai ;, zou tie jun ;
cheng yong yi ;, jiang ya zhuo ;, li jing ;, qu wei xing ;, wu min ;, yu yi ;, zhao hua cai ;, zou tie jun ;
..............page:1514-1519
The effect of small interfering RNA targeting TSG1O1 in breast cancer cells MDA-MB-435S
Cui Zeshi;,Li Chunyan;,Song Min;,Zhang Siyang;,Zhang Ying;
Cui Zeshi;,Li Chunyan;,Song Min;,Zhang Siyang;,Zhang Ying;
..............page:1519-1522
The development of a diagnosis platform for screening and real time quantitation of PML/RARα fusion gene in acute promyelocytic leukemia
chen xue zuo ;, cui zuo ;, gao bei bei ;, gao yuan ;, huang dan ;, kang zhi jie ;, li li ;, zuo jin song ;, yang yan ;
chen xue zuo ;, cui zuo ;, gao bei bei ;, gao yuan ;, huang dan ;, kang zhi jie ;, li li ;, zuo jin song ;, yang yan ;
..............page:1522-1526
The expression of miR-939 in human lung cancer and its influence on the cell cycle
han zhong qiu ;, peng hong xing ;, shi yu qin ;, wang ping ;, wu wen dan ;, xiong zuo ;, yang rong shi ;, zeng yu lan ;
han zhong qiu ;, peng hong xing ;, shi yu qin ;, wang ping ;, wu wen dan ;, xiong zuo ;, yang rong shi ;, zeng yu lan ;
..............page:1526-1529
Study of the vitro inhibition effect of Schisandra to breast cancer
Han Yanqiu;,Liu Shan;
Han Yanqiu;,Liu Shan;
..............page:1530-1534
The biological characteristics and distribution of co-culture DC-LAK cells after infusion in tumor-bearing mice
Chen Xin;,He Ming;,Sun Jie;,Zhang Xiaokun;
Chen Xin;,He Ming;,Sun Jie;,Zhang Xiaokun;
..............page:1535-1539
The joint effects and toxicities of Thalidomide and Arsenic Trioxide in the prevention of SMMC7721 xenograft tumor growth in nude mice
Chang Ren'an;,Liu Chun;,Lu Guangping;,Pan Jiqun;,Wu Ronghua;,Yu Zhijian;,Zhou Xuefeng;
Chang Ren'an;,Liu Chun;,Lu Guangping;,Pan Jiqun;,Wu Ronghua;,Yu Zhijian;,Zhou Xuefeng;
..............page:1540-1544
RNAi inhibitting the expression of OGT in esophagel cancer cells Eca-109
dang cheng xue ;, jiang jian tao ;, li shao min ;, ma yue feng ;, ma zhen chuan ;, qiao zhe ;, zhang jin ;, zhang wei ;, zhou bin ;
dang cheng xue ;, jiang jian tao ;, li shao min ;, ma yue feng ;, ma zhen chuan ;, qiao zhe ;, zhang jin ;, zhang wei ;, zhou bin ;
..............page:1544-1549
The protective mechanism of resveratrol on LPS induced human alveolar epithelial cells A549 apoptosis
cui li chun ;, du jian fei ;, geng hui sheng ;, liu jin peng ;, tian chun qin ;, wang jing ;, wang xuan ;, wei na ;
cui li chun ;, du jian fei ;, geng hui sheng ;, liu jin peng ;, tian chun qin ;, wang jing ;, wang xuan ;, wei na ;
..............page:1550-1553
The effects of intensity modulated radiotherapy for nasopharyngeal carcinoma on brachial plexus
Jiang Chaoyang;,Li Xiaokai;,Pan Xingguo;,Xian Jing;,Zhang Ling;
Jiang Chaoyang;,Li Xiaokai;,Pan Xingguo;,Xian Jing;,Zhang Ling;
..............page:1554-1556
Sebaceous carcinoma of the eyelid :A clinicopathological analysis
Chen Fang;,Fang Sangao;,Lin Li;,Ma Qiang;,Wang Yuanyuan;,Xiao Hualiang;
Chen Fang;,Fang Sangao;,Lin Li;,Ma Qiang;,Wang Yuanyuan;,Xiao Hualiang;
..............page:1557-1561
DNA ploidy analysis in the pathological diagnosis of parathyroid carcinoma
Li Dechang;,Li Wei;,Ren Li;,Wang Xiaomin;,Yue Ying;,Zhao Jiufei;,Zheng Jichun;
Li Dechang;,Li Wei;,Ren Li;,Wang Xiaomin;,Yue Ying;,Zhao Jiufei;,Zheng Jichun;
..............page:1561-1563
Clinical effect of Herceptin combined with vinorelbine and cisplatin in the treatment of metastatic breast cancer patients failed to anthracycline-based chemotherapy
Dong Chao;,Ren Hongxuan;,Yang Runxiang;,Yao Ping;,Zeng Limei;
Dong Chao;,Ren Hongxuan;,Yang Runxiang;,Yao Ping;,Zeng Limei;
..............page:1564-1566
The expression of uPA in triple negative breast cancer tissue and its clinical pathological significance
gao xiao yan ;, he na ;, jiang jian tao ;, ma xing cong ;, ma yi zuo ;, wei zuo zuo ;, xue xing huan ;, zhang shu qun ;
gao xiao yan ;, he na ;, jiang jian tao ;, ma xing cong ;, ma yi zuo ;, wei zuo zuo ;, xue xing huan ;, zhang shu qun ;
..............page:1567-1569
Correlation of expression of p21WAF1 gene with the clinical pathological feature of lung carcinoma
Li Lanju;,Liu Wei;,Meng Yan;,Wei Yiping;,Yue Hongwei;
Li Lanju;,Liu Wei;,Meng Yan;,Wei Yiping;,Yue Hongwei;
..............page:1570-1572
..............page:1572-1574
The content of Th17 in diabetic breast cancer cells
Cui Yuxiu;,Li Dongjie;,Ma Shaolin;,Wang Weijun;,Wang Yanli;
Cui Yuxiu;,Li Dongjie;,Ma Shaolin;,Wang Weijun;,Wang Yanli;
..............page:1575-1578
An evaluation on diagnostic value of CEA, CYRFA21-1, NSE in the malignant pleural effusion with ROC curves
She Chunyan;,Xia Shijun;,Xu Chong'an;,Zhang Xuemei;
She Chunyan;,Xia Shijun;,Xu Chong'an;,Zhang Xuemei;
..............page:1579-1581
Meta analysis of gefitinib and docetaxel for non-small cell lung cancer(NSCLC)
Dai Xiaoqian;,Fu Xiaoyan;,Ma Li;,Wei Suwen;
Dai Xiaoqian;,Fu Xiaoyan;,Ma Li;,Wei Suwen;
..............page:1581-1586
Efficacy of neoadjuvant chemotherapy regimen of TAC and AT for locally advanced breast cancer
Liu Haiying;,Liu Qilong;,Sun Yufang;,Xiong Bin;,Zhao Guangzhang;
Liu Haiying;,Liu Qilong;,Sun Yufang;,Xiong Bin;,Zhao Guangzhang;
..............page:1587-1589
The diagnostic value of medical thoracoscopy for malignant pleural effusion
Chen Ruilin;,Niu Qian;,Sun Gang;,Wang Jun;,Zhi Caiyan;
Chen Ruilin;,Niu Qian;,Sun Gang;,Wang Jun;,Zhi Caiyan;
..............page:1589-1591
Diagnosis and treatment of 39 cases of breast cancer patients with liver metastases
dai zhi jun ;, guan hai tao ;, kang hua feng ;, liu xiao xu ;, zuo wei li ;, wang xi jing ;, xue xing huan ;, zhang shu qun ;, zhao yang ;
dai zhi jun ;, guan hai tao ;, kang hua feng ;, liu xiao xu ;, zuo wei li ;, wang xi jing ;, xue xing huan ;, zhang shu qun ;, zhao yang ;
..............page:1592-1594
Study of lymph node metastasis and target delineation of thoracic esophageal cancer after three-field esophagectomy
Jiang Huayong;,Wang Yadi;,Xu Weidong;,Zhang Fuli;
Jiang Huayong;,Wang Yadi;,Xu Weidong;,Zhang Fuli;
..............page:1594-1596
The charateristic of MSCT in pulmonary neuroendocrine carcinoma and the analysis of pathology
Han Zhenguo;,Wang Yanyan;,Xin Lei;,Xu Shuming;,Zhao Zhikai;
Han Zhenguo;,Wang Yanyan;,Xin Lei;,Xu Shuming;,Zhao Zhikai;
..............page:1596-1598
Clinical observation of capecitabine maintain treatment on metastatic breast cancer
Shen Chuanhou;,Tao Xiongfei;,Zhen Zhenhua;
Shen Chuanhou;,Tao Xiongfei;,Zhen Zhenhua;
..............page:1599-1601
Pemetrexes combined with cisplatin/carboplatin to treat malignant pleural mesothelioma
Liu Yawei;,Nan Yan;,Song Lei;,Wang Yaru;,Wang Zheng;,Zhang Xiangye;
Liu Yawei;,Nan Yan;,Song Lei;,Wang Yaru;,Wang Zheng;,Zhang Xiangye;
..............page:1601-1603
Improved nasogastric tube feeding for patients with advanced oespohageal cancer complicated by oespohageal fistula
He Xiaoli;,Zhang Mei;,Zhang Xiaofang;
He Xiaoli;,Zhang Mei;,Zhang Xiaofang;
..............page:1603-1605
Pathological diagnosis and clinical analysis of sarcomatoid carcinomas of the urinary bladder
Liu Yili;,Wang Ping;,Xue Dongwei;,Zhang Xiuwei;
Liu Yili;,Wang Ping;,Xue Dongwei;,Zhang Xiuwei;
..............page:1605-1608
Value of lobaplantin as a combined chemotherapy drug with TACE for unresectable hepatocellular carcinoma
Lu Mingjian;,Peng Sheng;,Si Ting;,Yang Qiuxia;,Zhang Tao;
Lu Mingjian;,Peng Sheng;,Si Ting;,Yang Qiuxia;,Zhang Tao;
..............page:1609-1612
Expression and significance of Bcl-2 and p16 protein in the gastric cancer
Geng Ming;,Jing Hongbiao;,Li Peifeng;,Wang Cuicui;,Zheng Jinfeng;,Zhou Luting;
Geng Ming;,Jing Hongbiao;,Li Peifeng;,Wang Cuicui;,Zheng Jinfeng;,Zhou Luting;
..............page:1612-1614
A clinical analysis about laparoscope combined with intraoperative gastroscope to undergo local gastric resection for gastric neuroendocrine neoplasm
Hou Yali;,Qiu Jian;,Sun Shuiping;,Wang Guorong;
Hou Yali;,Qiu Jian;,Sun Shuiping;,Wang Guorong;
..............page:1615-1618
Methylation of T-cadherin promoter is associated with malignant biological behavior and prognosis in gastric cancer
Cao Wei;,Lv Haoyue;,Song Jianqing;,Zhao Junli;
Cao Wei;,Lv Haoyue;,Song Jianqing;,Zhao Junli;
..............page:1618-1623
Expression and clinical significance of NY-ESO-1 in transitional cell carcinoma of the bladder
Guo Hongzhi;,Liu Gang;,Song Yongsheng;,Wang Peng;,Wang Xiaotian;,Yin Bo;,Zhang Mo;
Guo Hongzhi;,Liu Gang;,Song Yongsheng;,Wang Peng;,Wang Xiaotian;,Yin Bo;,Zhang Mo;
..............page:1624-1626
The relationship between Survivin and Bcl-2 expression and chemoresistance in gastric carcinoma
Geng Ming;,Jing Hongbiao;,Li Peifeng;,Wang Cuicui;,Zhou Luting;
Geng Ming;,Jing Hongbiao;,Li Peifeng;,Wang Cuicui;,Zhou Luting;
..............page:1627-1629
Urothelial carcinoma of the renal pelvis with choriocarcinomatous features:A clinicopathologic analysis of 1 case
Wang Yingmei;,Yan Linli;,Yang Qiao;,Zhang Jing;,Zhou Ru;
Wang Yingmei;,Yan Linli;,Yang Qiao;,Zhang Jing;,Zhou Ru;
..............page:1630-1633
The effect of injectio arsenous acid on the serum levels of IGF-Ⅱ and IGFBP-2 in patients with middle or advanced primary liver cancer
Huang Laiji;,Xie Guofeng;,Ye Jiacai;,Zhang Xiuping;
Huang Laiji;,Xie Guofeng;,Ye Jiacai;,Zhang Xiuping;
..............page:1633-1635
Effect of interventional therapy on malignant islet cell tumor of liver metastasis after surgery:A report of eight cases and review of literature
Chang Jihong;,Shang Chunyu;,Zhang Liming;
Chang Jihong;,Shang Chunyu;,Zhang Liming;
..............page:1636-1637
The efficiency of endoscopic ultrasound guided neurolytic celiac plexus block for pancreatic carcinoma pain
Gao Chunxiang;,Gao Shiping;,Jing Yan;,Zhang Lin;
Gao Chunxiang;,Gao Shiping;,Jing Yan;,Zhang Lin;
..............page:1638-1640
The correlation between serum PSA combined PSAD and prostate diseases
Cai Lianming;,Chen Hanmin;,Li Rong;,Liu Lianbin;
Cai Lianming;,Chen Hanmin;,Li Rong;,Liu Lianbin;
..............page:1640-1643
The clinical observation of 23 cases with advanced pancreatic cancer treated with GEMOX combined with high intensity focused ultrasound
guo jing jing ;, tong jin long ;, wang li xue ;, xu zuo feng ;, zhang quan an ;, zheng qin ;, zhu chuan dong ;, zhu xiao fang ;
guo jing jing ;, tong jin long ;, wang li xue ;, xu zuo feng ;, zhang quan an ;, zheng qin ;, zhu chuan dong ;, zhu xiao fang ;
..............page:1643-1646
The efficacy of radiotherapy plus chemotherapy for left supraclavicular lymph nodes metastatic tumors
Chen Yongfa;,Lu Yiyu;,Pan Xingxi;,Tang Wubing;,Wu Churong;,Yang Wen;,Zhang Yongsheng;
Chen Yongfa;,Lu Yiyu;,Pan Xingxi;,Tang Wubing;,Wu Churong;,Yang Wen;,Zhang Yongsheng;
..............page:1646-1648
Therapeutic effect of 26 patients with superior vena cava syndrome
Tang Lei;,Wu Cuie;,Xuan Han;
Tang Lei;,Wu Cuie;,Xuan Han;
..............page:1649-1650
Preliminary study for risk factors of death in patients with chemotherapy-induced agranulocytosis
Gao Jianfei;,Qiu Guochao;,Rao Zhiguo;
Gao Jianfei;,Qiu Guochao;,Rao Zhiguo;
..............page:1651-1653
The protection of dexrazoxane to epirubicin on the cardiotoxicity
Jin Yongmin;,Li Xiangzi;,Piao Longzhen;,Piao Suzhou;,Shen Xionghu;,Sun Honghua;,Zhang Songnan;
Jin Yongmin;,Li Xiangzi;,Piao Longzhen;,Piao Suzhou;,Shen Xionghu;,Sun Honghua;,Zhang Songnan;
..............page:1653-1655
..............page:1656-1658
Expression of ING4 in ovarian tumor and its clinical significance
Cheng Li;,Liu Qian;,Niu Na;
Cheng Li;,Liu Qian;,Niu Na;
..............page:1658-1662
p-ERK protein expression of human ovarian cancer and its significance
chang bin ;, dan hong ying ;, du chun fang ;, du jin ze ;, jia zuo ;, liu ze yu ;, lu li xia ;, sun li li ;, zhu hui min ;
chang bin ;, dan hong ying ;, du chun fang ;, du jin ze ;, jia zuo ;, liu ze yu ;, lu li xia ;, sun li li ;, zhu hui min ;
..............page:1662-1666
Curative effects of whole body hyperthermia combined with chemotherapy in advanced ovarian cancer
Cai Yingquan;,Wang Guoqing;,Ying Mingjuan;,Zhao Xixia;,Zhou Min;
Cai Yingquan;,Wang Guoqing;,Ying Mingjuan;,Zhao Xixia;,Zhou Min;
..............page:1667-1668
Mesenchymal chondrosarcoma :A clinicopathological analysis of 3 cases
Du Juan;,Fang Sangao;,Lin Li;,Ma Qiang;,Xiao Hualiang;,Zhong Peng;
Du Juan;,Fang Sangao;,Lin Li;,Ma Qiang;,Xiao Hualiang;,Zhong Peng;
..............page:1669-1673
The therapeutic effect of zoledronic acid combined with chemotherapy in the treatment of myeloma bone disease
Li Chunxia;,Liu Yunhua;
Li Chunxia;,Liu Yunhua;
..............page:1673-1675
Effect of thalidomide combined with ICE regimen in the treatment of relapsed and refractory non-Hodgkin's lymphoma
Chai Xingxing;,He Yao;,Jiang Yajun;,Li Xiumei;,Zhu Guihua;,Zhuang Wanchuan;
Chai Xingxing;,He Yao;,Jiang Yajun;,Li Xiumei;,Zhu Guihua;,Zhuang Wanchuan;
..............page:1675-1677
Clinical and pathological analysis of angioimmunoblastic T-cell lymphoma
Ding Qi;,Qi Xiumin;,Zhang Rongrong;
Ding Qi;,Qi Xiumin;,Zhang Rongrong;
..............page:1678-1681
New craniospinal radiotherapy technology
Guo Yanhong;,Kong Wei;,Ma Jianping;,Shang Jun;,Xia Xinshe;,Yang Zhihua;,Ye Hongqiang;
Guo Yanhong;,Kong Wei;,Ma Jianping;,Shang Jun;,Xia Xinshe;,Yang Zhihua;,Ye Hongqiang;
..............page:1682-1685
The influence of different definition of organ at risk(OAR)on the plan of intensity-modulated radiotherapy(IMRT)for breast cancer radiotherapy
Gulizhareye·Aikula;,He Chunyu;,Munire·Mushajiang;,Simayili·Maimaitiniyayazi;,Wang Juwu;
Gulizhareye·Aikula;,He Chunyu;,Munire·Mushajiang;,Simayili·Maimaitiniyayazi;,Wang Juwu;
..............page:1685-1688
Case report of rapid progress of gallstones changing to gallbladder cystocarcinoma
Liu Peng;,Wang Heling;,Zhang Yu;,Zhou Pinyi;
Liu Peng;,Wang Heling;,Zhang Yu;,Zhou Pinyi;
..............page:1688-1690
Research progress on relevant predictive markers of radiation esophagitis
Liu Baorui;,Liu Jiang;,Qian Xiaoping;,Ren Wei;
Liu Baorui;,Liu Jiang;,Qian Xiaoping;,Ren Wei;
..............page:1690-1693
Advance research of Asbestos-induced pulmonary tumor
Bin Liu;,Lin Ziying;,Liu Gang;
Bin Liu;,Lin Ziying;,Liu Gang;
..............page:1694-1697
Research progress of MDFIC molecule
Se Linge;,Xia Haibin;
Se Linge;,Xia Haibin;
..............page:1697-1699
Research progress of circulating tumor cells in lung cancer
He Wenjie;,Jiang Bo;,Tu Changling;
He Wenjie;,Jiang Bo;,Tu Changling;
..............page:1700-1703
Targeting lymphangiogenesis autocrine axis to prevent tumor progression
Feng Chen;,Ren Fengyun;,Zhang Wei;
Feng Chen;,Ren Fengyun;,Zhang Wei;
..............page:1703-1706
Research progress on colorectal cancer biology treatment in clinical application
He Feng;,Liu Tao;,Lu Bin;,Shen Jie;,Xiang Fang;,Zhang Dan;
He Feng;,Liu Tao;,Lu Bin;,Shen Jie;,Xiang Fang;,Zhang Dan;
..............page:1707-1711
Research progress on the anti-tumor mechanism and reversal mechanism of drug resistance of β-elemene
Hu Xuejun;,Wang Ximing;
Hu Xuejun;,Wang Ximing;
..............page:1711-1714
E-cadherin and tumor metastasis
Chen Tao;,Li Yunxiao;
Chen Tao;,Li Yunxiao;
..............page:1715-1718
The research progress of cervical cancer micrometastases
Wei Xiangqun;,Wu Chunxiu;
Wei Xiangqun;,Wu Chunxiu;
..............page:1718-1720
Progress in the diagnosis and treatment of biochemical recurrence in prostatic cancer patients with definitive therapy
Zhai Minghui;,Zhao Huarong;
Zhai Minghui;,Zhao Huarong;
..............page:1721-1723
The research advances of 5t4 in tumor
Jiang Yao;,Wang Liying;,Zhang Hongbin;
Jiang Yao;,Wang Liying;,Zhang Hongbin;
..............page:1724-1728
..............page:1728-1732
mir-193b yu zhong liu xiang guan xing de yan jiu jin zhan
jiang qi sheng ;, lv jin ;, song xiu jun ;, zhu li na ;
jiang qi sheng ;, lv jin ;, song xiu jun ;, zhu li na ;
..............page:1733-1735
egr-1 ji yin shang you xin hao ji lian tong lu yu zhong liu fang she zhi liao xiang guan de yan jiu jin zhan
dong guang zuo ;, yuan hao ;, zhou hong ;
dong guang zuo ;, yuan hao ;, zhou hong ;
..............page:1735-1738